-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hyperkalemia is type 2 diabetes mellitus (T2DM) is a common complication, limits the best blocking renin - vascular angiotensin - aldosterone system agents, particularly in chronic kidney disease (CKD) patients
Diabetic blood vessels
Canagliflozin similarly reduced the incidence of laboratory-confirmed hyperkalemia (HR of 0.
Original source:
Brendon L Neuen.
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial
in this message